DouglasFrancisBeachMD
Oncology • Philadelphia, PAHematologic Oncology
Associate Program Director of Internal Medicine Residency at Pennsylvania Hospital; Clinical Assistant Professor, University of Pennsylvania; Director of CREP/Breast and Ovarian Cancer Program at Pennsylvania Hospital
Dr. Beach is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
230 W Washington Sq
Philadelphia, PA 19106Phone+1 215-829-6088
Summary
- Dr. Douglas Beach is an oncologist based in Philadelphia, PA, specialising in Hematologic Oncology. He completed his fellowship and residency in Hematology and Medical Oncology and Internal Medicine respectively at Cooper Medical School of Rowan University/Cooper University Hospital. His medical degree is from the Rutgers Robert Wood Johnson Medical School. Dr. Beach currently serves as an Assistant Professor of Medicine at the Hospital of the University of Pennsylvania. His areas of expertise include amyloidosis, non-hodgkin lymphoma, lung cancer, and hereditary breast/ovarian cancer. He has published significantly in his field and has been involved in multiple clinical trials, particularly focused on lymphomas.
Education & Training
Cooper Medical School of Rowan University/Cooper University HospitalFellowship, Hematology and Medical Oncology, 2009 - 2012- Cooper Medical School of Rowan University/Cooper University HospitalResidency, Internal Medicine, 2006 - 2009
Rutgers Robert Wood Johnson Medical SchoolClass of 2006
Certifications & Licensure
NJ State Medical License 2009 - 2025
PA State Medical License 2011 - 2024
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies Start of enrollment: 2013 Jan 02
- A Pilot Trial of AVD and Brentuximab Vedotin (SGN-35) in the Treatment of Stage III-IV HIV-associated Hodgkin Lymphoma Start of enrollment: 2015 Jun 01
- Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery Start of enrollment: 2015 Oct 21
- Join now to see all
Publications & Presentations
PubMed
- 54 citationsOutcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial.Anthony R. Mato, Lindsey E. Roeker, John N. Allan, John M. Pagel, Danielle M. Brander
American Journal of Hematology. 2018-11-01 - 5 citationsOn the generalizability of prostate cancer studies: why race mattersOhad Oren, M. Oren, Douglas F. Beach
Annals of Oncology. 2016-12-01 - Superior vena cava syndrome as an initial presentation of low-grade follicular lymphoma.Shakira Jeanene Grant, Simon Meykler, Doublas Beach
The Journal of Community and Supportive Oncology. 2014-11-01
Press Mentions
Beach-Rak Medicine LLC Debuts Its First App of the MD SeriesMay 28th, 2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
